MaaT Pharma’s PICASSO trial met its primary goal, so why is the melanoma efficacy picture still uncertain?
MaaT Pharma's PICASSO trial met its safety goal but showed similar melanoma responses. Discover what the results mean for MaaT034.
Pharma & Biotech